Jeff Yass’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Sell
10,048
-22,164
-69% -$4.77M ﹤0.01% 5987
2026
Q1
$6.47M Buy
32,212
+16,203
+101% +$3.35M ﹤0.01% 3812
2025
Q4
$3.31M Sell
16,009
-23,284
-59% -$4.65M ﹤0.01% 4706
2025
Q3
$7.04M Sell
39,293
-9,362
-19% -$1.59M ﹤0.01% 3555
2025
Q2
$7.85M Buy
48,655
+45,708
+1,551% +$7.28M ﹤0.01% 3201
2025
Q1
$501K Sell
2,947
-16,320
-85% -$2.83M ﹤0.01% 8902
2024
Q4
$3.2M Sell
19,267
-681
-3% -$116K ﹤0.01% 4363
2024
Q3
$3.43M Buy
+19,948
New +$3.3M ﹤0.01% 4303
2024
Q2
Sell
-6,972
Closed -$1.05M 12345
2024
Q1
$1.07M Sell
6,972
-33,090
-83% -$5.05M ﹤0.01% 6724
2023
Q4
$6.33M Buy
40,062
+8,206
+26% +$1.18M ﹤0.01% 3326
2023
Q3
$4.66M Buy
31,856
+13,971
+78% +$2.13M ﹤0.01% 3657
2023
Q2
$2.74M Buy
17,885
+14,075
+369% +$2.19M ﹤0.01% 4520
2023
Q1
$591K Sell
3,810
-28,453
-88% -$4.47M ﹤0.01% 8170
2022
Q4
$4.97M Buy
32,263
+3,312
+11% +$489K ﹤0.01% 3237
2022
Q3
$3.82M Sell
28,951
-25,563
-47% -$3.59M ﹤0.01% 3604
2022
Q2
$7.39M Buy
54,514
+6,848
+14% +$944K ﹤0.01% 2616
2022
Q1
$7.11M Buy
47,666
+28,149
+144% +$4.16M ﹤0.01% 3061
2021
Q4
$3.16M Sell
19,517
-8,934
-31% -$1.44M ﹤0.01% 4558
2021
Q3
$4.72M Buy
28,451
+16,367
+135% +$2.8M ﹤0.01% 4053
2021
Q2
$2.09M Sell
12,084
-22,598
-65% -$3.73M ﹤0.01% 5825
2021
Q1
$5.57M Buy
34,682
+14,132
+69% +$2.42M ﹤0.01% 3700
2020
Q4
$3.45M Sell
20,550
-9,960
-33% -$1.62M ﹤0.01% 4064
2020
Q3
$4.8M Buy
30,510
+14,328
+89% +$2.34M ﹤0.01% 3107
2020
Q2
$2.71M Buy
16,182
+7,817
+93% +$1.23M ﹤0.01% 3972
2020
Q1
$1.1M Sell
8,365
-22,593
-73% -$3.22M ﹤0.01% 5181
2019
Q4
$4.6M Sell
30,958
-21,576
-41% -$2.96M ﹤0.01% 3082
2019
Q3
$6.5M Buy
52,534
+18,269
+53% +$2.43M ﹤0.01% 2407
2019
Q2
$4.83M Buy
+34,265
New +$4.73M ﹤0.01% 2757
2018
Q3
Sell
-5,262
Closed -$796K 9503
2018
Q2
$737K Sell
5,262
-1,899
-27% -$261K ﹤0.01% 6024
2018
Q1
$952K Sell
7,161
-5,105
-42% -$697K ﹤0.01% 5352
2017
Q4
$1.53M Sell
12,266
-19,942
-62% -$2.46M ﹤0.01% 4424
2017
Q3
$3.99M Buy
+32,208
New +$3.81M ﹤0.01% 2808
2017
Q2
Sell
-21,090
Closed -$2.27M 9347
2017
Q1
$2.22M Buy
21,090
+12,638
+150% +$1.27M ﹤0.01% 3516
2016
Q4
$768K Buy
+8,452
New +$792K ﹤0.01% 6077
2016
Q3
Sell
-23,683
Closed -$2.32M 8569
2016
Q2
$2.12M Sell
23,683
-5,215
-18% -$479K ﹤0.01% 3463
2016
Q1
$2.53M Buy
28,898
+21,407
+286% +$1.89M ﹤0.01% 3324
2015
Q4
$847K Sell
7,491
-37,980
-84% -$4.09M ﹤0.01% 5752
2015
Q3
$4.61M Buy
45,471
+29,423
+183% +$3.5M ﹤0.01% 2786
2015
Q2
$1.99M Buy
16,048
+13,734
+594% +$1.66M ﹤0.01% 4720
2015
Q1
$274K Sell
2,314
-12,063
-84% -$1.36M ﹤0.01% 8130
2014
Q4
$1.47M Sell
14,377
-1,534
-10% -$150K ﹤0.01% 5085
2014
Q3
$1.46M Buy
15,911
+11,913
+298% +$1.03M ﹤0.01% 5189
2014
Q2
$329K Sell
3,998
-74,257
-95% -$5.68M ﹤0.01% 8218
2014
Q1
$6M Buy
78,255
+75,186
+2,450% +$5.87M ﹤0.01% 2639
2013
Q4
$212K Sell
3,069
-1,071
-26% -$70.3K ﹤0.01% 8169
2013
Q3
$268K Sell
4,140
-436,169
-99% -$27.6M ﹤0.01% 7375
2013
Q2
$25.6M Buy
+440,309
New +$25.2M 0.01% 921

Other funds holding FBT

Jeff Yass's FBT Position: Q2 2026 in Review

Jeff Yass reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 69% in Q2 2026, selling an estimated $4.77M and leaving 10,048 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #5987.

Jeff Yass first reported a position in FBT in Q2 2013 and has held it in 47 quarters since. The position peaked at $25.6M in Q2 2013. 338 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Jeff Yass held 10,048 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.49M as of Q2 2026.
  • Jeff Yass sold 22,164 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $4.77M.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5987 holding.
  • Jeff Yass first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 47 quarters since.
  • Jeff Yass's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25.6M in Q2 2013.
  • 338 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.